Linda Ferrer in Kearney, Nebraska

Home Nebraska Kearney

Linda Ferrer has Cardiovascular Disease (cardiology) as her primary medical specialty. Their primary office is: 816 22nd Ave in Kearney, Nebraska. There is an additional office location, for a total of two, for Linda Ferrer that can be viewed further down.

They're a part of the: Bryan Hospital Kearney medical group which has around 85 members. You can call their office at 308-865-2263 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Linda M Ferrer Office Phone and Directions

Linda Ferrer
Bryan Hospital Kearney
816 22nd Ave
Kearney, Nebraska 68845
308-865-2263

Patient Ratings
Please rate your experience with Linda Ferrer below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 308-865-2263

Enter a starting address:

Healthcare Info for Linda Ferrer

Medical School: Sorry, her university is not listed
Graduation Year: 2003
The Primary Medical Specialty for Linda Ferrer is listed as: Cardiovascular Disease (cardiology)
Approximate Years of Experience: 21
PAC (PECOS ID)#: 6002116290
NPI #: 1295113439
NPI Created On: 05/07/2015
NPI Last Updated Listed as: 11/03/2021
Primary Taxonomy Code: 207RC0000X
License Number:
33269
Listed Gender: Female

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788081005

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30